Influx of Ca 2+ through store-operated Ca 2+ channels (SOCs) is a central component of receptor-evoked Ca 2+ signals 1 . Orai channels are SOCs 2-4 that are gated by STIM1, a Ca 2+ sensor located in the ER 5,6 but how it gates and regulates the Orai channels is unknown. Here, we report the molecular basis for gating of Orais by STIM1. All Orai channels are fully activated by the conserved STIM1 amino acid fragment 344-442, which we termed SOAR (the STIM1 Orai activating region). SOAR acts in combination with STIM1 (450-485) to regulate the strength of interaction with Orai1. Activation of Orai1 by SOAR recapitulates all the kinetic properties of Orai1 activation by STIM1. However, mutations of STIM1 within SOAR prevent activation of Orai1 but not coclustering of STIM1 and Orai1 in response to Ca 2+ store depletion, indicating that STIM1-Orai1 co-clustering is not sufficient for Orai1 activation. An intact carboxy terminus α-helicial region of Orai is required for activation by SOAR. Deleting most of the Orai1 amino terminus impaired Orai1 activation by STIM1, but Orai1 Δ1-73 interacted with and was fully activated by SOAR. Accordingly, the characteristic inward rectification of Orai is mediated by an interaction between the polybasic STIM1 (672-685) and a Pro-rich region in the N terminus of Orai1. Hence, the essential properties of Orai1 function can be rationalized by interactions with discrete regions of STIM1.
Ca 2+ influx is a crucial step in receptor-evoked signalling, and occurs through plasma membrane channels named store-operated Ca 2+ influx channels (SOCs), which are activated in response to release of Ca 2+ from the endoplasmic reticulum (ER) 1 . Recently, the molecular determinants of SOCs and their gating have been elucidated. STIM1 is a Ca 2+ -binding protein that functions as the ER Ca 2+ sensor and activates SOCs 5, 6 . STIM1 is a multi-domain protein with N-terminal EF hand and SAM domains that reside in the ER lumen, a cytoplasmic region composed of an ERM (Ezrin/radixin/moesin) domain, a Ser/Pro-rich domain and a polybasic Lys-rich domain 5, 6 . In response to Ca 2+ release from the ER, Ca 2+ dissociates from the EF hand and STIM1 clusters next to the plasma membrane to activate the SOCs [5] [6] [7] [8] .
Two channel families have been identified as STIM1-regulated SOCs: the transient receptor potential canonical (TRPC) 9 and Orai channels [2] [3] [4] . TRPC channels function as non-selective, Ca 2+ -permeable channels 10 , whereas Orai1 is a Ca 2+ -selective, Ca 2+ -release-activated Ca 2+ (CRAC) channel [2] [3] [4] . The STIM1 ERM domain binds TRPC channels 7 , allowing their heteromultimerization 11 , whereas the Lys 684 and 685 residues of STIM1 gate TRPC channels by an electrostatic interaction with two conserved negative charges in TRP Box 2 of TRPC channels 12 . STIM1 is required for the Orais to function as channels 4, 13, 14 but it is not known how STIM1 gates and regulates the Orais. Gating of the native CRAC current 7 and of Orai1 (refs 15, 16) is mediated by the STIM1 C terminus, but does not require the STIM1 Ser/Pro and Lys domains 12 . A Pro-rich region in the N terminus of Orai1 is thought to be important for STIM1 gating of Orai1 (ref. 17 ). However, it has also been reported that deletion of the first 73 residues of Orai1, which includes the Pro-rich region, does not prevent activation of Orai1 by STIM1 (ref. 18 ). To better define gating and regulation of Orai1 by STIM1, we searched for the STIM1 domains required for gating and voltage-dependence of Orai1. CRAC channels 7 and Orai1 (refs 15, 16) are activated by the STIM1 C terminus, but the Ser/Pro and polybasic Lys domains are not required for activation of Orai1 (ref. 12) . We therefore searched for the minimal STIM1 domain that could fully activate Orai1. Drosophila melanogaster STIM1 terminates at the equivalent human STIM1 residue 485 (ref. 19) . Indeed, STIM1 (235-485) activates native SOCs and Orai1 (data not shown). Analysis of systematic N-and C-terminal deletions identified STIM1 (344-442) as the minimal sequence that fully activates Orai1. The effects of various STIM1 fragments evaluated in studies on spontaneous Ca 2+ influx (Fig. 1c ) are summarized in Fig. 1b , and example traces are shown in Fig. 1a . The STIM1 fragments had one of three effects: 1) they activated spontaneous Ca 2+ influx, 2) inhibited SOCs, or 3) had no effect. Store depletion by inhibition of SERCA with cyclopiazonic acid (CPA) showed that the STIM1 fragments did not deplete the stores. As STIM1 (344-442) is the minimal domain required for activation of Ca 2+ influx ( Fig. 1 ) and all Orai channels (see below), we termed it SOAR, for the STIM1 Orai-activating region.
To assess cell biological correlates of Orai1activation by STIM1, we monitored the distribution of EGFP-STIM1 fragments and mCherry-Orai1 in HEK293 cells ( Fig. 1e ; Supplementary Information, Fig. S1 ). In all cases, STIM1 constructs that activated Orai1 colocalized with Orai1 at the plasma membrane. Several constructs, such as SOAR, redistributed from the cytosol to the plasma membrane when coexpressed with Orai1, independently of the native STIM1. Other constructs associated with the plasma membrane when expressed alone, but knockdown of native Orai1 prevented their plasma membrane enrichment (STIM1 (344-460) in Fig. 1e ). N-and C-terminal truncations of SOAR that failed to activate Orai1 also failed to colocalize with Orai1 (Figs 1e; Supplementary Information, Fig. S1b ). Depletion of internal Ca 2+ stores had no further effect on their colocalization with Orai1 (data not shown). This is consistent with a recent report showing that the STIM1 C terminus does not cluster with Orai1 (ref. 20) . These data indicate a precise correlation between the ability of STIM1 fragments to localize to the plasma membrane with Orai1, and to activate the channel.
SOAR is conserved among vertebrate species ranging from human to zebrafish and in invertebrates, but with lower sequence identity for Caenorhabditis elegans ( Supplementary Information, Fig. S2a ). Attempts to purify bacterial SOAR were unsuccessful but we expressed and purified STIM1 (336-485). The CD spectra of STIM1 (336-485) ( Supplementary  Information, Fig. S2b ) indicate a 45% α-helical structure, which is comparable to the predicted 62%. Both gel filtration (red trace) and light scattering (blue trace) analyses indicate that STIM1 (336-485) exists as a dimer in solution ( Supplementary Information, Fig. S2c ). Recent work suggests that Orai1 functions as a tetramer 21, 22 and assembles with two STIM1 molecules to form the functional channel 21 . The dimer formation of STIM1 (336-485) is consistent with these findings.
The effect of SOAR on Orai1 current was measured at a SOAR to Orai1 expression ratio of 1:1, which is optimal for maximal activation of Orai1 ( Supplementary Information, Fig. S3 ). SOAR and the cytosolic STIM1 fragments that colocalized with Orai1 fully activated Orai1 (Fig. 2) , and SOAR activated Orai1 independently of the native STIM1 ( Fig. 2d ). Current measurement starting within 10 s of break-in showed that about l e t t e r s 50% of the Orai1 current induced by the STIM1 fragments was spontaneously active ( Fig. 2e) , with further activation probably due to chelation of cytoplasmic Ca 2+ by the slowly diffusing BAPTA. Importantly, all kinetic parameters of the Orai1 current activated by SOAR were identical to the parameters of Orai1 current activated by STIM1 ( Fig. 2a , b, f), and STIM1 and SOAR similarly activated the Na + current of the pore mutant Orai1 E106D (Fig. 2g ). The three Orais are activated by STIM1 but show different conductance, with Orai1>>Orai2>Orai3 (refs 14, 23); SOAR activates Orai2 and Orai3 with the same current density as STIM1 ( Supplementary Information, Fig. S4a -c). The Orai1 L273S mutation, which disrupts the Orai1 C terminus α-helix, inhibited interaction with and activation of Orai1 by STIM1 (ref. 15) . Similarly, SOAR did not colocalize with Orai1 L273S at the plasma membrane ( Fig. 3a) , and neither STIM1 nor SOAR activated Orai1 L273S (Fig. 3b ). Hence, activation of Orai1 requires interaction of SOAR with the Orai1 C terminus.
The Orai1 N terminus encompasses amino acids 1-86. Deletion of amino acids 1-73 (Orai Δ1-73 ) reduces its activation by STIM1 (ref. 18 ; Fig. 3c-e ). STIM1 poorly activated Orai1 Δ1-73 whereas, it was fully activated by SOAR and had the same properties as Orai1 activated by SOAR or STIM1. Orai1 Δ1-73 recruited SOAR to the plasma membrane and in response to store depletion, co-clustered with STIM1 at the plasma membrane ( Supplementary Information, Fig. S4d ). SOAR and STIM1 (344-460) co-immunoprecipitated equally well with Orai1 and with Orai1 Δ1-73 , but not with Orai1 L273S ( Supplementary Information, Fig. S4e ). The specificity of the co-immunoprecipitation was confirmed by the lack of co-immunoprecipitation of STIM1 (344-425) and Orai1 or Orai1 Δ1-73 . Neither SOAR nor STIM1 (344-460) co-immunoprecipitated with an 
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Figure 2
The properties of Orai1 activation by SOAR and the STIM1 fragments.
(a) The CRAC current was measured in HEK cells expressing Orai1 and the indicated STIM1 fragments. For these and all other current measurements, Orai1 was tagged with Flag-mCherry and the STIM1 fragments with EGFP. Preliminary experiments showed that the tags had no effect on the activity of the proteins. The cells were dialysed with a pipette solution containing BAPTA (10 mM) and external solution containing Ca 2+ (10 mM). The cells were then perfused with divalent-free medium (DFM). Here and in all figures, dashed lines show the zero current. (b) The I/V for each condition at the peak current, as marked by the filled symbols in a. (c) Mean ± s.e.m of 4 experiments in each condition. (d) Native STIM1 is not required for activation of Orai1 by SOAR. HEK cells treated with scrambled or siSTIM1 were transfected with Orai1 alone (control) or Orai1 and SOAR, and used to measure the CRAC current.
The columns show mean ± s.e.m of 4 experiments. The blot shows efficiency of knockdown (the full blot is shown in Supplementary Information, Fig. S7 ) (e) Current measurement started within 10 s of break-in using the recording conditions in a to evaluate the spontaneous current before substantial diffusion of BAPTA into the cells. The columns show mean ± s.e.m of 4 experiments. (f) Fast Ca 2+ -mediated inactivation of CRAC current was measured in cells expressing Orai1 and STIM1 or Orai1 and SOAR or STIM1 (344-470). After maximal activation of the current, the membrane potential was stepped up from a holding potential at 0 to -120 mV for 400 ms. (g) Activation of Na + current by Orai1 E106D was measured by dialysing the cells with pipette solution containing Cs + (140 mM) and BAPTA (10 mM) and bath solution containing Na + (140 mM). The cells were transfected with Orai1 and STIM1 or SOAR. The columns show mean ± s.e.m of 4 experiments.
Orai1 mutant lacking the C terminus (Orai1 ΔC ), but this mutant was mostly retained in the ER, which makes it less informative (data not shown). Hence, SOAR binding to and activation of Orai1 requires the C terminus but not the N terminus of Orai1.
Studies of TRPC1 activation by STIM1 indicate that STIM1 binding and gating are mediated by distinct regions of the molecule 12 . We searched for mutants of STIM1 that could distinguish between these properties for Orai1. Residues 344-350 of SOAR were essential for activation of Orai1 (Fig. 1b ). STIM1 LQ347/348AA and SOAR LQ347/348AA did not activate Orai1 (Fig. 4a ), and SOAR LQ347/348AA did not colocalize or coimmunoprecipitate with Orai1 ( Fig. 4c, f) . By contrast, when expressed alone, STIM1 LQ347/348AA was found in tubular-like structures in untreated cells and clustered into puncta in response to store depletion ( Fig. 4d ). Moreover, when co-expressed with Orai1, STIM1 LQ347/348AA co-clustered with Orai1 in cells with depleted stores (Fig. 4e, arrows) , and co-immunoprecipitated with Orai1 ( Fig. 4g ). Importantly, STIM1 LQ347/348AA was functional in stimulating TRPC1 ( Fig. 4h ), suggesting that the overall structure of STIM1 LQ347/348AA is not disrupted. Together, these results indicate that SOAR is essential for activation of Orai1 by STIM1. Furthermore, the interaction and co-clustering of STIM1 with Orai1 is not sufficient for activation of Orai1 by STIM1. This suggests that SOAR within STIM1 actively gates Orai1 to open the channel.
The differential action of SOAR versus STIM1 in activating Orai1 Δ1-73 ( Fig. 3 ) suggests that another domain in STIM1 normally interacts with the N terminus of Orai1 and this is required for the action of SOAR when it is part of STIM1. To examine this hypothesis, we noted that the N terminus of Orai contains Pro residues grouped at positions 3, 5, 7-9, 14, 17, 18, 39, 40 and 43-47. Mutation of Pro residues 14, 17, 18, 43, 44, and 45-47 to Ala had no effect on activation of Orai1 by either STIM1 or SOAR. Mutation of Pro 7-9 resulted in a mutant with low activity with STIM1 and SOAR (data not shown), independently of surface expression ( Supplementary Information, Fig. S6a ). However, Orai1 P3,5A and Orai1 P39,40A behaved similarly to Orai1 Δ1-73 , with respect to activation by STIM1 and SOAR ( Fig. 5a-c) . The I/V plots for activation of Orai1 P3,5A and Orai1 P39,40A by STIM1 are flattened at negative membrane potentials, with the channel becoming both inwardly and outwardly rectifying. This is illustrated by calculating the percentage increase in current on changing the membrane potential from -70 to -100 mV (Fig. 5f ), which shows increases of about 25% for Orai1 and only 5-7% for Orai1 P3,5A and Orai1 P39,40A . The pairs of Pro residues (3, 5) and (39, 40) are required to observe the change in the Orai1 I/V, as the single mutants Orai1 P3A , Orai1 P39A and Orai1 P40A behaved like wild-type Orai1 when activated by STIM1 (Fig. 5d ) or by SOAR (data not shown).
The reduced activation of Orai1 P3,5A and Orai1 P39,40A by STIM1 was not due to reduced surface expression ( Supplementary Information,  Fig. S6a ). To the extent tested, the properties of Orai1 P3,5A and Orai1 P39,40A activated by STIM1 (344-460) are similar to those of Orai1 activated by STIM1 ( Fig. 5b, d ; Supplementary Information, Fig. S5d ). The pore mutation E106D in the context of Orai1 P3,5A and Orai1 P39,40A activated by STIM1 or STIM1 (344-460) resulted in a large monovalent current, but with a small current with STIM1 ( Supplementary  Information, Fig. S5a-c) .
The preceding analysis supports a model in which the Orai1 N terminus interacts with a region of STIM1 that normally inhibits the action of SOAR. We examined a series of mutants and identified the polybasic Lys domain. STIM1 ΔK and point-mutations of Lys in the Lys domain rescued the reduced activation of Orai1 P3,5A by STIM1 ( Fig. 5g, h ; Supplementary  Information, Fig. S6b ). The same results were obtained with all of the STIM1 Lys domain mutants with Orai1 P39,40A (data not shown). However, the mutant in which all seven Lys domain residues were substituted by Glu did not activate Orai1 P3,5 (Fig. 5h ). Hence, an intact Lys domain is required for its interaction with the Orai1 mutants. These observations indicate that the positive charges within the Lys domain regulate the ability of SOAR to activate Orai1 in the context of wild-type STIM1. Consistent with this model, deletion of the Lys domain strongly enhances STIM1 binding to Orai1 ( Supplementary Information, Fig. S5e ). The present study reveals the molecular mechanism by which STIM1 gates Orai1 channels. SOAR within STIM1 is required and sufficient for full activation of all Orai channels by interacting with the C terminus of Orai1. The STIM1 C terminus multimerizes two Orai1 dimers to form the active channel 20 . STIM1 (336-485) exists as a dimer in solution ( Supplementary Information, Fig. S2c) . A potential mechanism for STIM1 gating of the Orais is that the Orai C termini prevent multimerization and assembly of functional channels. Binding of STIM1 molecules through their SOAR domains to the C termini of Orais can serve to deflect the C termini, thereby allowing assembly and opening of the channels. Hence, SOAR within STIM1 actively gates the Orai channels. Thus, clustering of Orai1 is neither sufficient nor necessary for activation of the channel. This is also supported by the function of STIM1 LQ/AA . Another STIM1 domain, the polybasic Lys-rich domain, regulates Orai1 and is separate from opening of Orai1 by SOAR. The Lys domain regulates the activity of Orai1 at negative membrane potentials by communicating with the Orai1 N-terminal Pro-rich domain. It seems that the Lys domain retards interaction of STIM1 with Orai1. In one model, the Lys-domain interacts with a region of Orai1 or STIM1 to prevent SOAR binding and this is reversed when the Lys domain interacts with the Orai1 N terminus.
SOAR and the Lys domain seem to have different roles in gating TRPC and Orai channels. SOAR within the STIM1 ERM domain participates in binding of STIM1 to TRPC channels, but is not sufficient to activate TRPC1 ( Supplementary Information, Fig. S6c ). The STIM1 Lys domain is essential for TRPC channel opening 12 , but inhibits Orai1. Under physiological conditions, the balance of association of the Lys domain and SOAR with the two channel types will determine the extent of regulation of Orai1 and TRPC channels by STIM1 and Ca 2+ influx.
METHODS
Solutions, reagents and clones. The TRPC1, STIM1 (wild-type, ΔK, All K/E, 681X), and Orai1 clones have been described previously 7, 11 . The human Orai2 and Orai3 clones were obtained from Open Biosystems (Orai2 clone no. BC069270 and Orai3 clone no. BC015555). Orai2 and Orai3 were cloned into mCherry-Red-p3×Flag vector 12 using NotI (5´) and SalI (3´). mCherry-Red is downstream and next to the 3×Flag and was cloned into the HindIII site of the multi-cloning region of the p3×Flag vector. SOAR and the various STIM1 fragments were generated by PCR and cloned into the pEGFP-C1 (Clontech) vector using EcoRI (5´ and 3´). Hence, all STIM1 fragments were tagged with EGFP at their N terminus. All point-mutations on STIM1 and Orai1 were generated using the site-directed mutagenesis kit (Stratagene). The antibodies used were monoclonal anti-STIM1 (BD Biosciences), polyclonal anti-tubulin (Cell Signaling Technology), monoclonal HRP-conjugated anti-GFP (Santa Cruz Biotechnology) and monoclonal anti-Flag and HRP-conjugated anti-Flag (Sigma-Aldrich). Anti-Flag antibodies were used for co-immunoprecipitation, whereas HRP-conjugated anti-GFP and anti-Flag antibodies were used for western blotting. The siRNA sequence used to knockdown human Orai1 is: 5´-GCCAUAAGACUGACCGACAGUUCCA-3´. A 6-h siRNA transfection of HEK293 cells was performed using Lipofectamine 2000 (day 1). The amount of siRNA used was 0.8 μg per 12-well with HEK cells at 80-90% confluence. After transferring the cells containing siRNA to 35-mm dish on day 2, they were transfected with plasmid for 6 h on day 3. The total amount of cDNA used per 35-mm dish was 0.5 μg ml -1 . Localization assays using confocal microscopy were performed and current was measured, or cells were collected and extracted for co-immunoprecipitation analysis the following day (day 4). Thus, the total time for cells exposed to siRNA was 72 h.
Western blotting and co-immunoprecipitation. Transfected cells were collected and lysed using 500 μl of binding buffer: 1× PBS buffer containing 1 mM NaVO3, 10 mM NaPyrophosphate, 50 mM NaF, pH 7.4, and 1% Triton X-100. The cell extracts were sonicated and insoluble material was spun down at 30,000g for 20 min. For the co-immunoprecipitation experiments, Myc antibody (1 μg) was added to cell extract (100 μl) and incubated for 1 h at 4 °C. Then, 50 μl of a 1:1 slurry of protein G Sepharose 4B beads was added to the antibody-extract mix and incubated for an additional 1 h at 4 °C. Beads were washed three times for 10 min with binding buffer and proteins were released from the beads with 50 μl of SDS-loading buffer. Protein (25 μl) was loaded onto 8% tris-glycine SDS-PAGE gels, which were transferred onto PVDF membrane for western blot analysis.
Biotinylation. Transfected cells were washed once with 1× PBS on ice. EZ-Link Sulfo-NHS-SS-Biotin (0.5 mg ml -1 ; Pierce) was added to the cells for 30 min on ice. Afterwards, the biotin was quenched with 50 mM glycine on ice for 10-15 min.
The cells were then processed as described above to make cell extracts. A 1:1 slurry of immobilized avidin beads (50 μl; Pierce) was added to the cell extract (100 μl) and incubated for 2 h at 4 C. Beads were washed three times for 10 min with binding buffer and proteins were released from the beads with SDS-loading buffer (50 μl). Protein (25 μl) was loaded onto 8% tris-glycine SDS-PAGE gels, which were transferred onto PVDF membrane for western blot analysis.
Measurement of Ca 2+ concentration. . The concentration of intracellular Ca 2+ was measured about 24 h after transfection using a PTI image acquisition system. Intracellular Ca 2+ was measured by loading the cells with Fura2 and recording Fura2 fluorescence at excitation wavelengths of 340 and 380 nm, and collecting the light emitted at wavelength above 500 nm. The intracellular Ca 2+ concentration is expressed as the 340/380 ratio.
Confocal imaging. After HEK cells were transfected with the chosen EGFP-STIM1 fragment with or without mCherry Red-Orai1, the cells were fixed with 4% paraformaldehyde and mounted onto microscope slides. Images were collected under ×400 magnification using the LaserSharp 2000 (Bio-Rad) software and a Bio-Rad confocal microscope.
Purification of STIM1 (336-485). The STIM1 (336-485) sequence was cloned into the pET 28 vector and expressed as an N-terminal 6×His fusion protein in BL21 Codon Plus cells (Stratagene), according to the manufacture's guidelines. The fusion protein was purified using TALON metal affinity resin (Clontech), according to the manufacturer's protocol, and the 6×His tag was removed using thrombin (Roche 24 . The 0% and 100% helix estimates used were 2,000 and 30,000 deg·cm 2 /dmol 25, 26 .
Current measurements. The whole-cell configuration was used to measure the Orai1 CRAC current in HEK cells co-transfected with Orai1, the Orai1 mutants and with STIM1, SOAR or the STIM1 fragments as detailed previously 7, 11, 12 with NaOH). The current was recorded by 400 ms rapid alterations of membrane potential (RAMPs) from -100 to +100 mV from a holding potential of 0 mV. The current recorded at -100 mV was used to plot the time course of current development and to calculate current density in pA/pF. The averages of multiple experiments are given as mean ± s.e.m of the number of experiments performed. TRPC1 current was measured in transiently transfected HEK cells by whole current recording, as described previously 11, 12, 27 . The pipette solution contained (in mM) 140 CsCl, 2 MgCl 2 , 1 ATP, 5 EGTA, 1.5 CaCl 2 (free Ca 2+ 70 nM) and 10 HEPES at pH 7.2 with CsOH. The bath solution contained (in mM) 140 NaCl or 140 NMDG-Cl, 5 KCl, 0.5 EGTA and 10 HEPES at pH 7.4 with NaOH or NMDG-OH -). Cells were transfected with TRPC1 and empty vector or TRPC1 and SOAR. RAMPs of -100 to +100 mV were used to record the TRPC1current. The cells were also transfected with the M3 receptor so that the current can be consistently activated by stimulating the cells with 100 μM carbachol. The current recorded at -100 mV was used to calculate current density as pA/pF. 
Figure S2
Multiple sequence alignment of SOAR, CD spectra and assembly of STIM1(336-485) (a) SOAR sequences were aligned using the MAFFT program and colored using the BOXSHADE program. The LQ site is colored turquoise. The cylinders above the alignment represent α-helices predicted by the program JPRED. The accession numbers used to create the alignment are as follows: Homo sapiens (Human: NP_003147.2); Pan troglodytes (Chimpanzee: XP_001160157); Equus caballus (Horse: XP_001499902.2); Bos taurus (Cattle: Q58CP9); Mus musculus (House Mouse: NP_033313); Rattus norvegicus (Norway Rat: NP_001101966); Sus scrofa (Pig: ABW03922); Gallus gallus (Chicken: NP_001026009); Xenopus laevis (African Clawed Frog: AAI26012); Danio rerio (Zebrafish: CAK10827.1); Drosophila melanogaster (Fruit Fly: AAF48542.2); Anopheles gambiae (Mosquito: EAA06485.3); Nasonia vitripennis (Jewel Wasp: XP_001605820.1); Caenorhabditis elegans (Nematode: ABG89384). b) A CD spectrum of purified STIM1(336-485) showing strong α helical content. c) UV absorbance (red trace) and Rayleigh light scattering (blue trace) chromatograms are shown of the purified STIM1(336-485) fragment eluting off of a Superdex 200 gel filtration column. The gel filtration elusion resulted in a peak position of the STIM1(336-485) of 15.5 ml, which corresponds to a predicted molecular weight of 35kDa. The calculated molecular weight from the Rayleigh light scattering peak is 33kDa. Hence, both methods report that STIM1(336-485) is a dimer (the monomer molecular weight is 17.7 kDa). 8) . For additional control, cells were transfected with SOAR, STIM1(344-460) and FLAG-mCherry (right blots). All Orai1 clones and STIM1 fragments are tagged with FLAG-mCherry and EGFP, respectively. The lysates were used to IP FLAG and blot for co-IP of STIM1 with anti-GFP. Full blots are shown in Fig. S7 .
Figure S5
Properties of Orai1 proline mutants (a-c) Na + current was measured in cells transfected with STIM1 (black traces) or STIM1(344-460) (red traces) and the proline and pore mutants Orai1(E106D, P3,5A) and Orai1(E106D, P39,40A). (c) is the mean±s.e.m. of 4 experiments. (d) The time course of CRAC current activation in cells expressing STIM1 and the indicated Orai1 proline mutants. The cells were perfused with bath solution containing 10 mM Ca 2+ and then in DFM. (e) Extracts were prepared from cells expressing Orai1+ STIM1 or Orai1+ STIM1(ΔK) and were used to IP STIM1 and test for co-IP of Orai1.
Figure S6
Expression of the Orai1 proline mutants, activation of Orai1(P3,5A) by STIM1 K domain mutants and inhibition of TRPC1 by SOAR (a) Lysates from cells transfected with the indicated Orai1 proline mutants were used to evaluate total and surface expression by a biotinylation assay. (b) CRAC current was measured in cells transfected with Orai1(P3,5A) and the indicated K-domain mutants. STIM1(681X) was generated by placing a stop codon after position 681. The traces are representative of 3-5 experiments with each condition. (c) Cells transfected with TRPC1 alone (black) or TRPC1 and SOAR (red) were used to measure the current activated by 100 μM carbachol. The columns are the mean±s.e.m of 4 experiments.
Figure S7
Full blot of native STIM1 (a), FLAG-mcherry-Orai1 (b) and of EFFP-STIM1 and EGFP-SOAR (c).
